cDNA accession Links to the sequence |
Tissue most 5' clones in red |
Match mRNA |
From bp to bp in mRNA |
From bp to bp in accs. |
Clone encodes complete protein (with AA variation) |
Features | Anomalies detected by AceView |
Accession match over (% length) |
Base differences relative to genome (% identity) |
AJ714303 | bone marrow | .a | 840 to 1008 | 14 to 181 | 168/181 (92 %) | 6 diff (96.7 %id) | |||
AK313628 | trachea | .a | 42 to 1307 | 1 to 1266 | T171M S243P | 1266/1266 (100 %) | 4 diff (99.7 %id) | ||
AW973026 | .b | 601 to 1112 | 512 to 1 | Submitted on the opposite strand | 512/512 (100 %) | 21 diff (95.9 %id) | |||
BC012613 | Bone marrow, acute myelogenous leukemia | .a | 39 to 1683 | 1 to 1645 | N63K T171M | tiling clone, available from MGC, AAA | 1645/1645 (100 %) | 6 diff (99.7 %id) | |
BI006148 | kidney_tumor | .a | 267 to 929 | 11 to 674 | 664/674 (98 %) | 38 diff (94.4 %id) | |||
BM272553 | insulinoma, Pancreas | .a | 567 to 1184 | 1 to 618 | Submitted on the opposite strand | 618/618 (100 %) | 2 diff (99.7 %id) | ||
BX105358 | lung | .c-u | 51 to 642 | 1 to 592 | exact | tiling clone, AAA | 592/592 (100 %) | 0 diff (100 %id) | |
AV740896 | cord Blood | .a | 25 to 527 | 47 to 531 | 479/593 (80 %) | 27 diff (95.5 %id) | |||
CD687232 | normal nasopharynx | .a | 40 to 673 | 20 to 653 | 634/653 (97 %) | 9 diff (98.7 %id) | |||
CD701870 | normal nasopharynx | .a | 40 to 293 | 39 to 292 | 254/292 (86 %) | 9 diff (97.0 %id) | |||
CD705432 | normal nasopharynx | .a | 40 to 394 | 18 to 373 | 356/373 (95 %) | 9 diff (97.6 %id) | |||
CA393298 | eye, RPE/choroid | .a | 55 to 592 | 1 to 538 | 538/538 (100 %) | 1 diff (99.9 %id) | |||
CV345504 | kidney_tumor | .a | 267 to 876 | 24 to 631 | 608/631 (96 %) | 8 diff (98.8 %id) | |||
AV713325 | .a | 1029 to 1532 | 1 to 504 | 504/504 (100 %) | 0 diff (100 %id) | ||||
AV711717 | .a | 1029 to 1532 | 1 to 504 | 504/504 (100 %) | 0 diff (100 %id) | ||||
BP227040 | .a | 35 to 621 | 1 to 587 | 587/587 (100 %) | 6 diff (99.0 %id) | ||||
BP228027 | .a | 41 to 608 | 1 to 566 | 566/566 (100 %) | 5 diff (99.2 %id) | ||||
BP228101 | .a | 42 to 622 | 1 to 582 | 582/582 (100 %) | 5 diff (99.2 %id) | ||||
EL733414 | mixed | .a | 54 to 694 | 1 to 637 | 637/644 (98 %) | 10 diff (98.5 %id) | |||
FN051856 | breast carcinoma | .b | 1194 to 1307 | 1 to 113 | tiling clone, | 113/114 (99 %) | 2 diff (98.3 %id) | ||
FN056718 | breast carcinoma | .c-u | 1 to 115 | 1 to 116 | tiling clone, | 116/116 (100 %) | 1 diff (99.2 %id) | ||
FN059357 | breast carcinoma | .b | 971 to 1068 | 7 to 104 | 98/104 (94 %) | 6 diff (94.3 %id) | |||
FN059359 | breast carcinoma | .b | 887 to 988 | 102 to 1 | Submitted on the opposite strand | 102/103 (99 %) | 0 diff (100 %id) | ||
FN071404 | breast carcinoma | .a | 737 to 820 | 1 to 83 | 83/83 (100 %) | 3 diff (96.4 %id) | |||
FN071846 | breast carcinoma | .b | 1056 to 1128 | 1 to 75 | 75/76 (98 %) | 4 diff (94.8 %id) | |||
FN072538 | breast carcinoma | .b | 1056 to 1130 | 1 to 76 | tiling clone, | 76/76 (100 %) | 5 diff (93.5 %id) | ||
FN075571 | breast carcinoma | .a | 744 to 847 | 1 to 103 | 103/103 (100 %) | 3 diff (97.1 %id) | |||
FN076104 | breast carcinoma | .a | 1080 to 1171 | 92 to 1 | Submitted on the opposite strand | 92/93 (98 %) | 0 diff (100 %id) | ||
FN082081 | breast carcinoma | .b | 1194 to 1303 | 1 to 109 | tiling clone, | 109/113 (96 %) | 4 diff (96.5 %id) | ||
FN098896 | breast carcinoma | .b | 796 to 895 | 1 to 97 | 97/100 (97 %) | 4 diff (96.0 %id) | |||
FN101354 | breast carcinoma | .b | 676 to 733 | 58 to 1 | Submitted on the opposite strand | 58/58 (100 %) | 0 diff (100 %id) | ||
FN103739 | breast carcinoma | .b | 855 to 925 | 1 to 70 | 70/71 (98 %) | 2 diff (97.2 %id) | |||
FN108259 | breast carcinoma | .b | 544 to 618 | 1 to 73 | 73/73 (100 %) | 5 diff (93.2 %id) | |||
FN115388 | breast carcinoma | .a | 985 to 1086 | 1 to 103 | 103/105 (98 %) | 2 diff (98.1 %id) | |||
FN121576 | breast carcinoma | .b | 942 to 1046 | 1 to 106 | 106/111 (95 %) | 3 diff (97.3 %id) | |||
FN122497 | breast carcinoma | .a | 851 to 948 | 1 to 95 | 95/95 (100 %) | 5 diff (94.8 %id) | |||
FN123973 | breast carcinoma | .b | 652 to 737 | 85 to 1 | Submitted on the opposite strand | 85/88 (96 %) | 5 diff (94.4 %id) | ||
FN124084 | breast carcinoma | .b | 998 to 1100 | 1 to 104 | 104/104 (100 %) | 1 diff (99.1 %id) | |||
FN127891 | breast carcinoma | .a | 1049 to 1150 | 1 to 103 | 103/103 (100 %) | 1 diff (99.1 %id) | |||
FN130861 | breast carcinoma | .b | 772 to 847 | 77 to 1 | Submitted on the opposite strand | 77/78 (98 %) | 2 diff (97.5 %id) | ||
FN136277 | breast carcinoma | .b | 1023 to 1109 | 1 to 90 | 90/91 (98 %) | 5 diff (94.6 %id) | |||
FN136802 | breast carcinoma | .a | 770 to 866 | 1 to 94 | 94/94 (100 %) | 4 diff (95.8 %id) | |||
FN145045 | breast carcinoma | .b | 821 to 941 | 117 to 1 | Submitted on the opposite strand | 117/117 (100 %) | 4 diff (96.6 %id) | ||
FN148485 | breast carcinoma | .b | 972 to 1068 | 1 to 94 | 94/94 (100 %) | 3 diff (96.9 %id) | |||
FN162886 | breast carcinoma | .a | 832 to 921 | 88 to 1 | Submitted on the opposite strand | 88/94 (93 %) | 6 diff (93.7 %id) | ||
FN168646 | breast carcinoma | .a | 851 to 948 | 98 to 1 | Submitted on the opposite strand | 98/98 (100 %) | 2 diff (98.0 %id) | ||
FN169271 | breast carcinoma | .b | 850 to 965 | 117 to 1 | Submitted on the opposite strand | 117/117 (100 %) | 1 diff (99.2 %id) | ||
FN173542 | breast carcinoma | .d-u | 1 to 86 | 1 to 87 | I17N P18T L19I T20D S22Q ... | tiling clone, | 87/87 (100 %) | 4 diff (95.5 %id) | |
GD148689 | .b | 1049 to 1106 | 1 to 57 | AAA | 57/57 (100 %) | 2 diff (96.5 %id) | |||
GD159672 | .b | 1048 to 1114 | 1 to 67 | 67/78 (85 %) | 2 diff (97.5 %id) | ||||
DA587602 | lung | .a | 41 to 573 | 2 to 534 | capped | 533/533 (100 %) | 3 diff (99.5 %id) | ||
DA592375 | lung | .a | 46 to 614 | 2 to 571 | capped | 570/570 (100 %) | 2 diff (99.7 %id) | ||
AU107265 | .a | 42 to 91 | 1 to 50 | 50/50 (100 %) | 1 diff (98.0 %id) | ||||
BP260555 | small intestine | .a | 42 to 624 | 1 to 583 | 583/583 (100 %) | 2 diff (99.7 %id) | |||
AU107266 | .a | 42 to 91 | 1 to 50 | 50/50 (100 %) | 2 diff (96.0 %id) | ||||
BP261355 | small intestine | .a | 42 to 624 | 1 to 583 | 583/583 (100 %) | 3 diff (99.5 %id) | |||
BP262575 | small intestine | .a | 42 to 622 | 1 to 581 | 581/581 (100 %) | 6 diff (99.0 %id) | |||
BP263761 | small intestine | .a | 42 to 622 | 1 to 582 | 582/582 (100 %) | 11 diff (98.2 %id) | |||
T64223 | lung | .a | 1414 to 1681 | 283 to 10 | 274/290 (94 %) | 0 diff (100 %id) | |||
T64409 | lung | .a | 751 to 970 | 1 to 208 | 208/208 (100 %) | 16 diff (92.4 %id) | |||
N79582 | lung | .c-u | 470 to 642 | 173 to 1 | fully sequenced, | 173/173 (100 %) | 0 diff (100 %id) | ||
W16617 | lung | .c-u | 51 to 500 | 1 to 442 | exact | fully sequenced, | 442/442 (100 %) | 1 diff (99.8 %id) | |
AA233142. matches multiple genes | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .b | 662 to 1096 | 442 to 1 | also hits gene C11orf95 | 442/442 (100 %) | 53 diff (88.1 %id) | ||
AA233718 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .a | 830 to 1326 | 1 to 497 | 497/497 (100 %) | 0 diff (100 %id) | |||
AA548892 | normal prostate, Prostate | .b | 543 to 1113 | 566 to 1 | 566/587 (96 %) | 9 diff (98.5 %id) | |||
AA974649 | Kidney, kidney tumor | .b | 583 to 1106 | 538 to 17 | tiling clone, AAA | 522/522 (100 %) | 32 diff (93.9 %id) | ||
AI092738 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .b | 634 to 1094 | 453 to 1 | 453/456 (99 %) | 51 diff (88.9 %id) | |||
AI669644 | uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors | .b | 543 to 1105 | 564 to 1 | 564/610 (92 %) | 6 diff (99.1 %id) | |||
AI925693 | poorly differentiated adenocarcinoma withsignet ring cell features, stomach | .b | 494 to 1219 | 724 to 1 | tiling clone, | 724/724 (100 %) | 12 diff (98.4 %id) | ||
AI961715 | thymus, pooled | .b | 554 to 1098 | 555 to 13 | AAA | 543/579 (93 %) | 30 diff (94.9 %id) | ||
BF508919 | .a | 969 to 1683 | 732 to 18 | AAA | 715/715 (100 %) | 1 diff (99.9 %id) | |||
BE326998 | Kidney | .a | 1055 to 1684 | 630 to 1 | 630/630 (100 %) | 2 diff (99.7 %id) | |||
BF002788 | Prostate | .b | 817 to 1094 | 278 to 1 | 278/278 (100 %) | 1 diff (99.7 %id) | |||
BF478157 | pooled germ cell tumors | .b | 840 to 1098 | 269 to 11 | AAA | 259/261 (99 %) | 2 diff (99.3 %id) | ||
BF242520 | bone marrow, from acute myelogenous leukemia | .a | 42 to 688 | 1 to 641 | 641/875 (73 %) | 17 diff (98.1 %id) | |||
BF241145 | bone marrow, from acute myelogenous leukemia | .b | 543 to 1107 | 14 to 575 | 562/577 (97 %) | 23 diff (96.1 %id) | |||
BG501260 | adenocarcinoma, Prostate | .a | 1 to 685 | 1 to 702 | tiling clone, | 702/702 (100 %) | 31 diff (95.6 %id) | ||
BG537482 | lung | .a | 42 to 425 | 1 to 388 | 388/526 (73 %) | 5 diff (99.1 %id) | |||
BI769240 | pooled lung and spleen | .a | 53 to 896 | 1 to 859 | 856/859 (99 %) | 40 diff (95.4 %id) | |||
CK822804 | insulinoma, Pancreas | .a | 618 to 1172 | 1 to 555 | Submitted on the opposite strand | 555/555 (100 %) | 0 diff (100 %id) | ||
CK822805 | insulinoma, Pancreas | .b | 544 to 1094 | 551 to 1 | tiling clone, | Submitted on the opposite strand | 551/567 (97 %) | 5 diff (99.2 %id) | |
BU160770 | bone marrow, from acute myelogenous leukemia | .a | 118 to 734 | 1 to 619 | 619/838 (73 %) | 17 diff (98.0 %id) | |||
CD245136 | White Matter | .a | 118 to 829 | 1 to 720 | 720/888 (81 %) | 16 diff (98.2 %id) | |||
TI_57183256 | .a | 53 to 896 | 30 to 888 | 856/888 (96 %) | 46 diff (94.9 %id) | ||||
AU100115 | .a | 42 to 341 | 1 to 300 | 300/300 (100 %) | 2 diff (99.4 %id) | ||||
AU107268 | .a | 42 to 91 | 1 to 50 | 50/50 (100 %) | 1 diff (98.0 %id) | ||||
BP292937 | lung | .a | 42 to 623 | 1 to 582 | 582/582 (100 %) | 3 diff (99.5 %id) | |||
M27717 | .a | 54 to 1675 | 1 to 1622 | T171M | 1622/1622 (100 %) | 2 diff (99.9 %id) | |||
AV760428 | bone marrow | .a | 24 to 960 | 1 to 925 | 925/1252 (73 %) | 42 diff (96.7 %id) | |||
NM_001870.2 | .a | 2 to 1683 | 1 to 1682 | exact | RefSeq, AAA | 1682/1682 (100 %) | 0 diff (100 %id) | ||
DA885989 | .b | 1 to 545 | 2 to 546 | tiling clone, capped | 545/545 (100 %) | 0 diff (100 %id) | |||
BM769163 | stomach | .a | 547 to 1019 | 1 to 473 | 473/473 (100 %) | 6 diff (98.8 %id) | |||
S40234 | .a | 381 to 1307 | 1 to 927 | 927/927 (100 %) | 6 diff (99.4 %id) | ||||
TI_1948242519 | .a | 42 to 1113 | 122 to 1186 | 1065/1348 (79 %) | 48 diff (96.5 %id) | ||||
TI_1948242520 | .a | 42 to 1035 | 123 to 1114 | AAA | 992/1382 (71 %) | 31 diff (97.8 %id) | |||
TI_1948242521 | .a | 627 to 1313 | 808 to 122 | 687/1254 (54 %) | 9 diff (99.3 %id) | ||||
TI_1948242809 | .a | 42 to 1018 | 116 to 1098 | 983/1395 (70 %) | 38 diff (97.3 %id) | ||||
TI_1948242810 | .a | 42 to 1034 | 118 to 1099 | 982/1351 (72 %) | 38 diff (97.2 %id) | ||||
TI_1948242811 | .a | 425 to 1313 | 1017 to 121 | 897/1288 (69 %) | 28 diff (97.9 %id) | ||||
TI_1948243094 | .a | 42 to 831 | 115 to 905 | 791/1389 (56 %) | 13 diff (99.1 %id) | ||||
TI_1948243095 | .a | 42 to 831 | 117 to 906 | 790/1343 (58 %) | 13 diff (99.1 %id) | ||||
TI_1948243096 | .a | 414 to 1313 | 1027 to 121 | 905/1295 (69 %) | 21 diff (98.4 %id) | ||||
TI_1948243097 | .a | 832 to 1313 | 592 to 104 | 489/1408 (34 %) | 20 diff (98.6 %id) | ||||
TI_1948243383 | .a | 42 to 1035 | 117 to 1104 | 988/1381 (71 %) | 35 diff (97.5 %id) | ||||
TI_1948243384 | .a | 627 to 1313 | 809 to 118 | 692/1327 (52 %) | 8 diff (99.4 %id) | ||||
DA927496 | small intestine | .a | 46 to 597 | 9 to 560 | capped | 552/552 (100 %) | 1 diff (99.9 %id) | ||
DA965065 | stomach | .a | 43 to 619 | 2 to 578 | capped | 577/577 (100 %) | 1 diff (99.9 %id) | ||
DR005288 | Prostate | .a | 52 to 745 | 1 to 694 | tiling clone, | 694/694 (100 %) | 3 diff (99.6 %id) | ||
DB027802 | testis | .a | 44 to 642 | 2 to 601 | capped | 600/600 (100 %) | 2 diff (99.7 %id) | ||
DB048509 | testis | .a | 43 to 606 | 2 to 565 | capped | 564/564 (100 %) | 1 diff (99.9 %id) | ||
DB120462 | thymus | .a | 42 to 600 | 2 to 561 | capped | 560/560 (100 %) | 3 diff (99.5 %id) | ||
DB124365 | thymus | .a | 44 to 598 | 2 to 556 | capped | 555/555 (100 %) | 1 diff (99.9 %id) | ||
DB201938 | trachea | .a | 43 to 597 | 2 to 556 | capped | 555/555 (100 %) | 1 diff (99.9 %id) | ||
DB248135 | uterus | .a | 43 to 557 | 2 to 516 | capped | 515/516 (99 %) | 2 diff (99.7 %id) | ||
DB265100 | uterus | .a | 43 to 633 | 2 to 593 | capped | 592/592 (100 %) | 3 diff (99.5 %id) | ||
AW207722 | .a | 42 to 831 | 117 to 906 | AAA | Suspected internal deletion, this clone was ignored | 790/1343 (58 %) | 13 diff (99.1 %id) | ||
TI_1948243096 | .a | 414 to 1313 | 1027 to 121 | 905/1295 (69 %) | 21 diff (98.4 %id) | ||||
TI_1948243097 | .a | 832 to 1313 | 592 to 104 | 489/1408 (34 %) | 20 diff (98.6 %id) | ||||
TI_1948243383 | .a | 42 to 1035 | 117 to 1104 | 988/1381 (71 %) | 35 diff (97.5 %id) | ||||
TI_1948243384 | .a | 627 to 1313 | 809 to 118 | 692/1327 (52 %) | 8 diff (99.4 %id) | ||||
DA927496 | small intestine | .a | 46 to 597 | 9 to 560 | capped | 552/552 (100 %) | 1 diff (99.9 %id) | ||
DA965065 | stomach | .a | 43 to 619 | 2 to 578 | capped | 577/577 (100 %) | 1 diff (99.9 %id) | ||
DR005288 | Prostate | .a | 52 to 745 | 1 to 694 | tiling clone, | 694/694 (100 %) | 3 diff (99.6 %id) | ||
DB027802 | testis | .a | 44 to 642 | 2 to 601 | capped | 600/600 (100 %) | 2 diff (99.7 %id) | ||
DB048509 | testis | .a | 43 to 606 | 2 to 565 | capped | 564/564 (100 %) | 1 diff (99.9 %id) | ||
DB120462 | thymus | .a | 42 to 600 | 2 to 561 | capped | 560/560 (100 %) | 3 diff (99.5 %id) | ||
DB124365 | thymus | .a | 44 to 598 | 2 to 556 | capped | 555/555 (100 %) | 1 diff (99.9 %id) | ||
DB201938 | trachea | .a | 43 to 597 | 2 to 556 | capped | 555/555 (100 %) | 1 diff (99.9 %id) | ||
DB248135 | uterus | .a | 43 to 557 | 2 to 516 | capped | 515/516 (99 %) | 2 diff (99.7 %id) | ||
DB265100 | uterus | .a | 43 to 633 | 2 to 593 | capped | 592/592 (100 %) | 3 diff (99.5 %id) |
? | Gene Summary | Gene on genome | mRNA:.a, .b, .c-u, .d-u | Alternative mRNAs features, proteins, introns, exons, sequences | Expression Tissue | Function, regulation, related genes DC |